Navigation Links
Media Advisory - Atlantica BioEnergy Task Force Leaders' Roundtable
Date:11/19/2008

- FPInnovations New Brunswick - Groupe Savoie - Province of - J.D. Irving, Limited Nova Scotia - Maine Forest - State of Maine Products Council - University of - Maine Pulp & Maine Paper Association - University of - NB Power New Brunswick When: ---- The following agenda events are open to the media: Monday, November 24 - Networking Reception: 6 p.m. to 7 p.m. - Gala Evening: 7 p.m. to 10 p.m. with greetings from dignitaries and keynote speech by Gary Reiner, Senior Vice-President and Chief Information Officer of GE. Tuesday, November 25 - Summary Breakfast: 7:30 a.m. to 9 a.m. Where: ----- The Fairmont Algonquin St. Andrews by-the-Sea, New Brunswick
'/>"/>
SOURCE Atlantica BioEnergy Task Force
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AUDIO from Medialink and GlaxoSmithKline: Fiber Key in Managing Irritable Bowel Syndrome (IBS) Symptoms
2. Mediatech Moves to Prince William County Innovation Park
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
6. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Scientists Using Social Media to Inform Lab Purchasing Decisions
11. NEWSWEEK: Media Lead Sheet/December 10, 2007 Issue (on newsstands Monday, December 3).

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... The Appignani Bioethics...ation, held a panel discussion today at the Nation...chnologies in biomedical sciences and climate chan...Andrew Light, both of the Center for American Prog...olitical angles. ,, A video of the event will ...
(Date:11/9/2009)...9 /PRNewswire-Asia/ -- The pharma and biotech sect...e companies are facing significant,pressure to cha...costs, calls for,lower prices and a greater regula...nancial crisis have made the work of creating new ...es are being forced to globalize their R&D,ope...
(Date:11/9/2009)...r 9 Following the provision of cli...Administration (FDA), privately,owned UK company D...national.com ) has been informed that its innovati...rded an Orphan-Drug,designation for the treatment ... ALS, also known as Lou Gehrig,s disease, is the m...
(Date:11/6/2009).... 6 BioSpecifics Technol...company developing first-in-class collagenase-base...for the third quarter ended September 30, 2009. ,...f this year, the FDA,s Arthritis Advisory Committe...approval of XIAFLEX(TM) for the treatment of Dupuy...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3Pharma and Biotech Leaders to Converge in Shanghai 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6
...ence,Corporation (Nasdaq: CSCX ), a global leader...bilitation, and informatics products, announced to...nancial results on Wednesday,April 30, 2008 after ...erence call with analysts and investors for 4:30 p...for the first quarter and current business,develop...
...cancer would find a noninvasive method to determin...ause low levels of oxygen in a tumor have been lin... to image the surrounding organs and tissues at th...umors in mice by Murali Krishna and colleagues, at...importance of this technical advance for furtherin...
...st-selling,biologics developed during the boom yea... hormone (hGH) and insulin, have lost patent,prote...y represent a market,of $40 billion. This opens up...atory hurdles can be overcome, according to a new ...orld Market for Biosimilars., Worldwide interest ...
Other Biology Technology:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles 2
(Date:11/9/2009)...David Queller and Joan Strassmann argue in a new p...n components, from the genetic level on up, give a...ing is an animal, a plant, a bacteria or a colony...e an organism, such as individuality or even membe... achieve organismality. What is necessary, they ar...
(Date:11/9/2009)... / b3c newswire / - Today, TNO, a Dutch contrac...ican organization for contract research and consul...etter of intent with regard to TNOs dynamic in vi...tent proposes a collaboration in which Seventh Wav...n in North America. The TIM systems will be used t...
(Date:11/8/2009)... a gene through deletion of genetic material on ch...lities in learning and behavior, said a consortium...( www.bcm.edu ) in a report that appears online to...search goes about 95 percent of the way to pinning... to this gene," said Dr. Arthur L. Beaudet ( http:...
Breaking Biology News(10 mins):What is the meaning of 'one'? 2What is the meaning of 'one'? 3TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Developmental delay could stem from nicotinic receptor deletion 2Diagnostic tools and innovative therapies improve patient prognosis 53431 1Diagnostic tools and innovative therapies improve patient prognosis 53431 2Diagnostic tools and innovative therapies improve patient prognosis 53431 3Diagnostic tools and innovative therapies improve patient prognosis 53431 4Diagnostic tools and innovative therapies improve patient prognosis 53431 5Diagnostic tools and innovative therapies improve patient prognosis 53431 6Rock Climbing Injury Rate Soaring 53430 1Rock Climbing Injury Rate Soaring 53430 2Men Around the World Seek Cosmetic Surgery 53428 1Men Around the World Seek Cosmetic Surgery 53428 2
...sor of Clinical Tropical Medicine at the London Sc...d the first Hideyo Noguchi Africa Prize for resear...eir Majesties the Emperor and Empress of Japan at ...ideyo Noguchi Prize aims to award individuals with...research and health services, and seeks to encoura...
... Savage-Rumbaugh, Scientist With Special Standing ...eld of ape language and cognition studies, recentl...egree conferred in the 103-year history of her alm... , Savage-Rumbaugh, an internationally known prim...trated that through early rearing experiences, bon...
...local-source energy. Faster, more reliable technol...anguage. Medical care tailored to your DNA, or neu...ological diseases and injuries. , Five University...tures of energy, health, and technology as part of...they received this year from the National Science ...
Other Biology News:Professor Brian Greenwood awarded first Hideyo Noguchi Africa Award 2Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 2Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 3Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 4Ape language pioneer Savage-Rumbaugh receives honorary Ph.D. from alma mater 5Pitt faculty receive awards to explore next-generation technologies 2Pitt faculty receive awards to explore next-generation technologies 3Pitt faculty receive awards to explore next-generation technologies 4
Luminex 100 IS System from Luminex Corporation
GIBCO Water Distilled Sterile from Invitrogen
GIBCO Water distilled from Invitrogen
Yeast Deletion Parental Strains S. cerevisiae Hansen BY4742 from Invitrogen
Biology Products: